244 related articles for article (PubMed ID: 29860330)
1. Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.
Trabert B; Poole EM; White E; Visvanathan K; Adami HO; Anderson GL; Brasky TM; Brinton LA; Fortner RT; Gaudet M; Hartge P; Hoffman-Bolton J; Jones M; Lacey JV; Larsson SC; Mackenzie GG; Schouten LJ; Sandler DP; O'Brien K; Patel AV; Peters U; Prizment A; Robien K; Setiawan VW; Swerdlow A; van den Brandt PA; Weiderpass E; Wilkens LR; Wolk A; Wentzensen N; Tworoger SS;
J Natl Cancer Inst; 2019 Feb; 111(2):137-145. PubMed ID: 29860330
[TBL] [Abstract][Full Text] [Related]
2. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
3. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
Trabert B; Ness RB; Lo-Ciganic WH; Murphy MA; Goode EL; Poole EM; Brinton LA; Webb PM; Nagle CM; Jordan SJ; ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Lurie G; Kjær SK; Hogdall E; Jensen A; Cramer DW; Terry KL; Vitonis A; Bandera EV; Olson S; King MG; Chandran U; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike MC; Berchuck A; Schildkraut JM; Wentzensen N;
J Natl Cancer Inst; 2014 Feb; 106(2):djt431. PubMed ID: 24503200
[TBL] [Abstract][Full Text] [Related]
4. Aspirin, other NSAIDs, and ovarian cancer risk (United States).
Fairfield KM; Hunter DJ; Fuchs CS; Colditz GA; Hankinson SE
Cancer Causes Control; 2002 Aug; 13(6):535-42. PubMed ID: 12195643
[TBL] [Abstract][Full Text] [Related]
5. Analgesic medication use and risk of epithelial ovarian cancer in African American women.
Peres LC; Camacho F; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Crankshaw S; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry P; Wang F; Schildkraut JM
Br J Cancer; 2016 Mar; 114(7):819-25. PubMed ID: 26908324
[TBL] [Abstract][Full Text] [Related]
6. Medication use and risk of ovarian carcinoma: a prospective study.
Lacey JV; Sherman ME; Hartge P; Schatzkin A; Schairer C
Int J Cancer; 2004 Jan; 108(2):281-6. PubMed ID: 14639616
[TBL] [Abstract][Full Text] [Related]
7. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
8. Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study.
Majidi A; Na R; Jordan SJ; DeFazio A; Obermair A; Friedlander M; Grant P; Webb PM
J Natl Cancer Inst; 2023 May; 115(5):570-577. PubMed ID: 36744914
[TBL] [Abstract][Full Text] [Related]
9. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.
Nagle CM; Ibiebele TI; DeFazio A; Protani MM; Webb PM;
Cancer Epidemiol; 2015 Apr; 39(2):196-9. PubMed ID: 25666512
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.
Baandrup L; Faber MT; Christensen J; Jensen A; Andersen KK; Friis S; Kjaer SK
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):245-55. PubMed ID: 23240575
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
13. Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.
Ammundsen HB; Faber MT; Jensen A; Høgdall E; Blaakaer J; Høgdall C; Kjaer SK
Acta Obstet Gynecol Scand; 2012 Sep; 91(9):1094-102. PubMed ID: 22646488
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
Sahasrabuddhe VV; Gunja MZ; Graubard BI; Trabert B; Schwartz LM; Park Y; Hollenbeck AR; Freedman ND; McGlynn KA
J Natl Cancer Inst; 2012 Dec; 104(23):1808-14. PubMed ID: 23197492
[TBL] [Abstract][Full Text] [Related]
15. Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.
Pinheiro SP; Tworoger SS; Cramer DW; Rosner BA; Hankinson SE
Am J Epidemiol; 2009 Jun; 169(11):1378-87. PubMed ID: 19342401
[TBL] [Abstract][Full Text] [Related]
16. Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.
Setiawan VW; Matsuno RK; Lurie G; Wilkens LR; Carney ME; Henderson BE; Kolonel LN; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1441-9. PubMed ID: 22665579
[TBL] [Abstract][Full Text] [Related]
17. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
Dixon SC; Nagle CM; Wentzensen N; Trabert B; Beeghly-Fadiel A; Schildkraut JM; Moysich KB; deFazio A; ; Risch HA; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Ness RB; Edwards RP; Jensen A; Kjær SK; Høgdall E; Berchuck A; Cramer DW; Terry KL; Poole EM; Bandera EV; Paddock LE; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Pike MC; Webb PM
Br J Cancer; 2017 Apr; 116(9):1223-1228. PubMed ID: 28350790
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.
Murphy MA; Trabert B; Yang HP; Park Y; Brinton LA; Hartge P; Sherman ME; Hollenbeck A; Wentzensen N
Cancer Causes Control; 2012 Nov; 23(11):1839-52. PubMed ID: 22972000
[TBL] [Abstract][Full Text] [Related]
19. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.
Asgari MM; Maruti SS; White E
J Natl Cancer Inst; 2008 Jul; 100(13):967-71. PubMed ID: 18577752
[TBL] [Abstract][Full Text] [Related]
20. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer.
Lo-Ciganic WH; Zgibor JC; Bunker CH; Moysich KB; Edwards RP; Ness RB
Epidemiology; 2012 Mar; 23(2):311-9. PubMed ID: 22252409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
